| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9005738 | Clinical Therapeutics | 2005 | 15 Pages |
Abstract
In this study, 24 weeks of treatment with muraglitazar 2.5 or 5 mg was an effective treatment option for these patients with type 2 diabetes whose disease was inadequately controlled with diet and exercise.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
MD, PhD Buse, MD Rubin, MD, PhD Frederich, PhD Viraswami-Appanna, MD, MHA Lin, MD Montoro, MD Shockey, MD Davidson,